Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Dickason David Create: Alert

All | News | Filings
Date FiledTypeDescription
10/06/2020 4 Dickason David (SVP of Pre-Clinical Prod. Dev.) has filed a Form 4 on RespireRx Pharmaceuticals Inc.
Txns: Granted 2,000,000 options to buy @ $0.0054, valued at $10.8k

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy